Telerehabilitation in People With Parkinson's Disease

Summary

Although TeleRehabilitation (TR) is widely accepted as an appropriate model for the provision of professional health services in the field of physiotherapy, with already established standards, guidelines and policies, there are still few studies in the literature on the use of TR as a rehabilitation tool in people with Parkinson's Disease (PD). Therefore, further studies on the efficacy of TR in the management of motor and non-motor symptoms of PD are needed. The study TEMPO aims at assessing the efficacy (in terms of autonomy in carrying out the activities of daily life) of a home TR program based on serious games in people with PD compared to conventional day-hospital treatment.

Eligibility

Inclusion Criteria:

* age between 30 and 80 years;
* diagnosis of Parkinson's Disease according to the "Movement Disorders Society's diagnostic criteria";
* Hoehn \& Yahr (H\&Y) score between 2 and 3 (ON-state);
* absence of dyskinesias assessed by the MDS-UPDRS with a score to items 4.1 and 4.2 ≤ 2;
* absence of cognitive impairment measured by the MoCA total score ≥ 18;
* stabilized drug treatment;
* have access to the Internet for TR;
* have a caregiver available during rehabilitation sessions in TR;
* have sufficient cognitive and linguistic level to understand and comply with study procedures;
* sign informed consent.

Exclusion Criteria:

* having any cognitive problems or low compliance that prevent using the TR system;
* other neurological pathologies, psychiatric complications or personality disorders;
* musculoskeletal diseases that impair movement;
* presence of dyskinesias assessed by the MDS-UPDRS with a score to items 4.1 and 4.2 \> 2;
* presence of cognitive impairment measured by the MoCA total score \< 18;
* severe cognitive or linguistic deficits (inability to understand and comply with study procedures);
* presence of blurred or low vision problems;
* hearing and speech impairment affecting participation in the system;
* absence of signature of the informed consent.

Conditions1

Browse More Trials